Arobase: A phase III trial of exemestane (Exe) and bevacizumab (BEV) as maintenance therapy in patients (pts) with metastatic breast cancer (MBC) treated in first line with paclitaxel (P) and BEV—A Gineco study.
2014 ◽
Vol 32
(15_suppl)
◽
pp. 501-501
◽
Keyword(s):
Keyword(s):
2006 ◽
Vol 94
(9)
◽
pp. 1233-1236
◽
Keyword(s):
2011 ◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 515-515
◽
Keyword(s):
Keyword(s):
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 627-627
◽
Keyword(s):
2004 ◽
Vol 22
(14_suppl)
◽
pp. 515-515
◽
Keyword(s):
2021 ◽
Keyword(s):
2013 ◽
Keyword(s):